Moximed

News

Press Release

First Patients Treated in a New Randomized Controlled Trial Evaluating the MISHA® Knee System vs Non-Surgical Treatment for Knee Osteoarthritis

Press Release

Brian Donovan Joins Moximed as Chief Operating Officer

CMS Grants New Procedure Code for the MISHA® Knee System

Press Release

Michael Mydra Joins Moximed as Senior Vice President of Reimbursement and Market Access

Press Release

Robert Spomer Joins Moximed as Senior Vice President of Sales

Press Release

Moximed Completes Closing of Series D Financing for $91 Million to Accelerate Commercialization of MISHA® Knee System, an Implantable Shock Absorber for Knee Osteoarthritis

Press Release

Moximed, Inc. Names Christopher Gleason as Chief Executive Officer

Press Release

James Leech Joins Moximed as Chief Financial and Strategy Officer

Press Release

Moximed Announces Appointment of Dave Amerson to Board of Directors

Press Release

Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States

Press Release

Favorable Five-Year Survivorship of Implantable Shock Absorber and Reduction of Arthroplasty Risk in High-Risk Patients Reported in Peer-Reviewed Publications

Press Release

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Press Release

Peer-Reviewed Publication Shows Superiority of Moximed’s MISHA™ Knee System

Press Release

Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

Press Release

Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis

Interested in MISHA?

CONTACT US